SCHEMBL1675178

SCHEMBL1675178

Cc1csc(N(C)c2ncnc3ccc(-c4ccc(C(C)O)o4)cc23)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 16/20 0.44
CLK1 P49759 8/20 0.44
CLK2 P49760 7/20 0.44
DYRK1B Q9Y463 7/20 0.44
DYRK1A Q13627 6/20 0.44
CLK3 P49761 3/20 0.43
CYP1A2 P05177 11/20 0.38
CYP3A4 P08684 10/20 0.38
CYP2C19 P33261 7/20 0.38
CYP2D6 P10635 7/20 0.38
ALDH1A1 P00352 6/20 0.38
TSHR P16473 6/20 0.38
MAPK1 P28482 5/20 0.38
CYP2C9 P11712 2/20 0.38
PIK3C2B O00750 1/20 0.37
PIK3C2G O75747 1/20 0.37
PIK3CG P48736 1/20 0.37
MAP2K5 Q13163 1/20 0.37
MAP3K19 Q56UN5 1/20 0.37
PIP4K2C Q8TBX8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675083 0.85 CLK4 (0.61) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675105 0.85 CLK4 (0.48) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675109 0.84 CLK4 (0.49) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675179 0.84 CLK4 (0.52) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675151 0.80 CLK4 (0.46) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675010 0.80 CLK4 (0.43) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675221 0.79 CLK1 (0.49) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675097 0.76 CLK4 (0.77) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675187 0.71 CLK4 (0.39) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675201 0.70 CLK4 (0.67) CLK4CLK1CLK2DYRK1BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed